Loading...
Immunotherapy strategy of EGFR mutant lung cancer
EGFR-mutant lung cancer is an important molecular subtype in Asia considering that almost 40%-50% of patients with lung adenocarcinoma in Asian carry the active EGFR mutaiton. People have greatly anticipated the efficacy of PD-1/PD-L1 monoclonal antibody in lung cancer treatment but anti-PD-1/PD-L1...
Na minha lista:
| Udgivet i: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6220136/ https://ncbi.nlm.nih.gov/pubmed/30416860 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|